Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
- DOI
- 10.1016/j.vaccine.2022.01.043
- Published
- 2022-01-31
- Container
- Vaccine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2022.01.043,
title = {Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.},
author = {Janssen YF and Feitsma EA and Boersma HH and Alleva DG and Lancaster TM and Sathiyaseelan T and Murikipudi S and Delpero AR and Scully MM and Ragupathy R and Kotha S and Haworth JR and Shah NJ and Rao V and Nagre S and Ronca SE and Green FM and Aminetzah A and Sollie F and Kruijff S and Brom M and van Dam GM and Zion TC.},
year = {2022},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2022.01.043},
url = {https://doi.org/10.1016/j.vaccine.2022.01.043}
}RIS
TY - JOUR TI - Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. AU - Janssen YF AU - Feitsma EA AU - Boersma HH AU - Alleva DG AU - Lancaster TM AU - Sathiyaseelan T AU - Murikipudi S AU - Delpero AR AU - Scully MM AU - Ragupathy R AU - Kotha S AU - Haworth JR AU - Shah NJ AU - Rao V AU - Nagre S AU - Ronca SE AU - Green FM AU - Aminetzah A AU - Sollie F AU - Kruijff S AU - Brom M AU - van Dam GM AU - Zion TC. PY - 2022 JO - Vaccine DO - 10.1016/j.vaccine.2022.01.043 UR - https://doi.org/10.1016/j.vaccine.2022.01.043 ER -
APA
YF, J., EA, F., HH, B., DG, A., TM, L., T, S., S, M., AR, D., MM, S., R, R., S, K., JR, H., NJ, S., V, R., S, N., SE, R., FM, G., A, A., F, S., S, K., M, B., GM, V. D., & TC., Z. (2022). Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.. Vaccine. https://doi.org/10.1016/j.vaccine.2022.01.043
Source records
- europe-pmc · retrieved 2026-09-26T23:58:46.509Z